OR WAIT 15 SECS
The US Department of Health and Human Services (HHS, Washington, DC) will distribute more than $1 billion in contracts to accelerate the development of cell-based production technologies for influenza vaccines.
The US Department of Health and HumanServices (HHS, Washington, DC, www.hhs.gov) willdistribute more than $1 billion in contracts to accelerate thedevelopment of cell-based production technologies for influenzavaccines. This technique employs cell cultures rather than chicken eggs(as do most vaccine manufacturing techniques) for primary production,which greatly shortens the production time (see Pharmaceutical Technology's April2006 Special Report, "Process Considerations for Cell-Based InfluenzaVaccines").
The funds, which were part of President Bush's $3.3-billion plan toprotect the United States against pandemics, were divided into fivecontracts that will be distributed over the next five years: